Balyasny Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7K | Sell |
17,743
-292,517
| -94% | -$210K | ﹤0.01% | 1924 |
|
|
2025
Q1 | $456K | Buy |
+310,260
| New | +$456K | ﹤0.01% | 1595 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2165 |
|
|
2024
Q1 | – | Sell |
-21,660
| Closed | -$248K | – | 2201 |
|
|
2023
Q4 | $248K | Sell |
21,660
-8,248
| -28% | -$94.4K | ﹤0.01% | 1680 |
|
|
2023
Q3 | $288K | Sell |
29,908
-1,658,105
| -98% | -$16M | ﹤0.01% | 1461 |
|
|
2023
Q2 | $18M | Buy |
1,688,013
+737,277
| +78% | +$7.84M | 0.04% | 463 |
|
|
2023
Q1 | $10M | Buy |
+950,736
| New | +$10M | 0.03% | 606 |
|
|
2022
Q3 | – | Sell |
-118,980
| Closed | -$1.37M | – | 2539 |
|
|
2022
Q2 | $1.37M | Buy |
+118,980
| New | +$1.37M | ﹤0.01% | 1296 |
|
|
2020
Q3 | – | Sell |
-31,670
| Closed | -$327K | – | 1203 |
|
|
2020
Q2 | $327K | Buy |
31,670
+18,883
| +148% | +$195K | ﹤0.01% | 816 |
|
|
2020
Q1 | $129K | Buy |
+12,787
| New | +$129K | ﹤0.01% | 947 |
|
|
2019
Q3 | – | Sell |
-20,747
| Closed | -$227K | – | 1220 |
|
|
2019
Q2 | $227K | Buy |
20,747
+5,313
| +34% | +$58.1K | ﹤0.01% | 1246 |
|
|
2019
Q1 | $175K | Sell |
15,434
-19,439
| -56% | -$220K | ﹤0.01% | 1252 |
|
|
2018
Q4 | $303K | Buy |
+34,873
| New | +$303K | ﹤0.01% | 1127 |
|
|
2018
Q3 | – | Sell |
-20,790
| Closed | -$333K | – | 1597 |
|
|
2018
Q2 | $333K | Buy |
20,790
+4,466
| +27% | +$71.5K | ﹤0.01% | 1301 |
|
|
2018
Q1 | $211K | Buy |
+16,324
| New | +$211K | ﹤0.01% | 1552 |
|